Biomass burning-whether from wildfires, wood stoves or agricultural fires-sends massive amounts of tiny particles and chemicals into the air.

Kairos Pharma (KAPA) announced that the company presented preclinical data on its investigational compounds KROS 101 and KROS 401 during the ...

2017年5月， 武汉大学口腔医院 在International Journal of Nanomedicine（IF6.6002/2区）期刊上发表了一篇论文。在 发表8年后 ，因 图片组内重复 在pubpeer上被读者质疑。 论文题为 “A ...

Enhanced quantity and functionality of natural killer (NK) cells in hepatocellular carcinoma (HCC) have been associated with improved prognosis and survival. Therefore, NK cell-based immunotherapy has ...

Key findings• Gene expression profile analyses revealed lower expression of inflammation/immune promotion, cytotoxicity, and cell proliferation ...

Avalon GloboCare Corp. ("Avalon" or the "Company") (NASDAQ: ALBT), a developer of innovative precision diagnostics and laboratory services, announced ...

Anti-CD20 mAbs were originally created to treat B cell proliferative diseases such as non-Hodgkin's lymphoma and chronic ...

Localized Cytokine Induction: The technology facilitates cytokine responses localized to tumor engagement, improving CAR cell cytotoxicity, survival, and proliferation while simultaneously activating ...

Treatment with a cold atmospheric plasma reduced the recurrence rate of melanoma tumours after surgery by roughly 50% ...

US FDA grants breakthrough therapy designation to Innate Pharma’s lacutamab for relapsed or refractory Sézary syndrome: Marseille, France Tuesday, February 18, 2025, 12:00 Hrs ...

Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) ("Innate" or the "Company") today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation (BTD) to ...